Download
TMH514485.pdf 432,83KB
WeightNameValue
1000 Titel
  • Effect of Methylene Blue Pathogen Inactivation on the Integrity of Immunoglobulin M and G
1000 Autor/in
  1. Raster, Johannes |
  2. Zimmermann, Kathrin |
  3. Wesche, Jan |
  4. Aurich, Konstanze |
  5. Greinacher, Andreas |
  6. Selleng, Kathleen |
1000 Verlag
  • S. Karger AG
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-02-25
1000 Erschienen in
1000 Quellenangabe
  • 48(3):148-153
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1159/000514485 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215996/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:p>&lt;b&gt;&lt;i&gt;Introduction:&lt;/i&gt;&lt;/b&gt; In the light of the ongoing SARS-CoV-2 pandemic, convalescent plasma is a treatment option for CO­VID-19. In contrast to usual therapeutic plasma, the therapeutic agents of convalescent plasma do not represent clotting factor activities, but immunoglobulins. Quarantine storage of convalescent plasma as a measure to reduce the risk of pathogen transmission is not feasible. Therefore, pathogen inactivation (e.g., Theraflex®-MB, Macopharma, Mouvaux, France) is an attractive option. Data on the impact of pathogen inactivation by methylene blue (MB) treatment on antibody integrity are sparse. &lt;b&gt;&lt;i&gt;Methods:&lt;/i&gt;&lt;/b&gt; Antigen-specific binding capacity was tested before and after MB treatment of plasma (&lt;i&gt;n&lt;/i&gt; = 10). IgG and IgM isoagglutinin titers were tested by agglutination in increasing dilutions. Furthermore, the binding of anti-EBV and anti-tetanus toxin IgG to their specific antigens was assessed by ELISA, and IgG binding to Fc receptors was assessed by flow cytometry using THP-1 cells expressing FcRI and FcRII. &lt;b&gt;&lt;i&gt;Results:&lt;/i&gt;&lt;/b&gt; There was no significant difference in the isoagglutinin titers, the antigen binding capacity of anti-EBV and anti-tetanus toxin IgG, as well as the Fc receptor binding capacity before and after MB treatment of plasma. &lt;b&gt;&lt;i&gt;Conclusion:&lt;/i&gt;&lt;/b&gt; MB treatment of plasma does not inhibit the binding capacity of IgM and IgG to their epitopes, or the Fc receptor interaction of IgG. Based on these results, MB treatment of convalescent plasma is appropriate to reduce the risk of pathogen transmission if quarantine storage is omitted. </jats:p>
1000 Sacherschließung
lokal Immunoglobulin M
lokal Immunoglobulin G
lokal Pathogen inactivation
lokal Methylene blue
lokal Research Article
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0001-8418-5038|https://frl.publisso.de/adhoc/uri/WmltbWVybWFubiwgS2F0aHJpbg==|https://frl.publisso.de/adhoc/uri/V2VzY2hlLCBKYW4=|https://frl.publisso.de/adhoc/uri/QXVyaWNoLCBLb25zdGFuemU=|https://orcid.org/0000-0001-8343-7336|https://frl.publisso.de/adhoc/uri/U2VsbGVuZywgS2F0aGxlZW4=
1000 Hinweis
  • DeepGreen-ID: c58515900ab74f39a6a2b7002b142640 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6478419.rdf
1000 Erstellt am 2024-05-21T15:13:03.287+0200
1000 Erstellt von 322
1000 beschreibt frl:6478419
1000 Zuletzt bearbeitet Wed May 22 10:48:28 CEST 2024
1000 Objekt bearb. Wed May 22 10:48:28 CEST 2024
1000 Vgl. frl:6478419
1000 Oai Id
  1. oai:frl.publisso.de:frl:6478419 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source